# VARUBI
> **NDA208399** · New Drug Application · Sponsor: TERSERA · Approved 2017-10-25
## Drug
- **FDA Application Number:** NDA208399
- **Application type:** New Drug Application
- **Brand name:** VARUBI
- **Generic name:** Rolapitant Hydrochloride
- **Active ingredients:** ROLAPITANT HYDROCHLORIDE
- **Dosage form:** EMULSION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** TERSERA
- **First approval:** 2017-10-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208399)
---
*AI Analytics · CC0 1.0*